Drug Patents owned by Xeris

1. List of Gvoke Hypopen drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9649364 XERIS Methods for producing stable therapeutic formulations in aprotic polar solvents
Apr, 2036

(13 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Sep 10, 2022

Drugs and Companies using GLUCAGON ingredient

Market Authorisation Date: 10 September, 2019

Treatment: Treatment of severe hypoglycemia

Dosage: SOLUTION;SUBCUTANEOUS

More Information on Dosage

GVOKE HYPOPEN family patents

11

United States

2

China

2

South Africa

2

European Union

1

Hong Kong

1

Korea, Republic of

1

Brazil

1

Australia

1

Canada

1

Israel

1

EA

1

Mexico

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in